Preparing for future pandemics
CEPI, the Coalition for Epidemic Preparedness Innovations, is a global partnership working to accelerate the development of vaccines and other biologic countermeasures against epidemic and pandemic threats.
Find out more
Latest News
Latest News
Fama Sakho: My Fellowship at CEPI
CEPI's Global South Fellow discusses her experience so far.
CEPI partners with Ethris to increase access to RNA vaccines through spray-dry technique
Funding will support development of spray-dried, thermostable RNA vaccines
Accessing innovation: Aurélia Nguyen’s drive for science to benefit all
For Intl Day of Women and Girls in Science, Aurelia Nguyen reflects on her career as a woman in science
Pushing mRNA vaccine development timelines to new speeds
New technology could streamline production of mRNA and improve global access
Groundbreaking study in Rwanda to unlock new insights into Marburg virus immunity
Rwandans who recently recovered from Marburg infection will participate in the study to help unlock clues about the body’s response to the virus.
Progressing the 100 Days Mission for greater global health security
A closer look at the progress made towards the 100 Days Mission for vaccines in 2024
Bringing together all the pieces of the Lassa fever vaccine puzzle
CEPI is working with partners to speed up licensure of a vaccine and enable equitable access to future doses.
Dr Njoki Kimani: My Fellowship at CEPI
Dr Njoki Kimani chats with us about her Global South Fellowship
New CEPI funding to spearhead pandemic preparedness research
The University of Saskatchewan’s Vaccine and Infectious Disease Organization (VIDO) is advancing their broadly protective coronavirus vaccine candidate.
Afrigen to develop human mRNA Rift Valley fever vaccine
CEPI funding will advance the vaccine candidate through preclinical development and Phase I trials.
Latest News
We want to create a world in which epidemics and pandemics are no longer a threat to humanity.
CEPI is working to galvanise the development of new vaccines and other biologic countermeasures against diseases that could cause the next devastating epidemic or pandemic.
Our approach
Research and development
CEPI is leading a broad range of ambitious programmes that aim to substantially reduce global epidemic and pandemic risk.
Calls for Proposals
Innovators worldwide are invited to apply to our scientific programmes to advance the development and manufacture of vaccines and tools against epidemic and pandemic threats.
Manufacturing and supply chain
CEPI is bolstering global manufacturing capacity in underserved regions and harnessing innovative technologies to improve the speed, scale and access of vaccine manufacturing in response to epidemic and pandemic threats.
The Viral Most Wanted
Join CEPI’s disease detectives as they investigate the viral families that have threatened human life for centuries.
$12.5 trillion
IMF’s estimate cost of the COVID-19 pandemic to the global economy through 2024
50+
Number of CEPI-supported vaccine candidates or platform technologies.
$2.8 billion
The minimum average cost to progress one vaccine each against 11 WHO priority infectious diseases
Emerging infectious diseases affect us all. They do not respect borders.
A commitment to equitable access informs every aspect of our work. It is core to CEPI’s vision of a world in which epidemics and pandemics are no longer a threat to humanity.
CEPI take a systems approach to equitable access, seeking to enable equitable access within a broad ecosystem of national and international public and private sector partners and networks.
We work towards this goal by enabling equitable access directly through financial investments and partnerships, and indirectly through advocacy and policy contributions to the evolving ecosystem.
